Compound MYH7 Mutations: Risk Stratification Challenges in an Affected Family

Arafat Hammad1, Amy Yeung1, Howard Goldschmidt2

  • 1Department of Internal Medicine, Valley Health System/Icahn School of Medicine at Mount Sinai, Paramus, New Jersey, USA.

JACC. Case Reports
|August 8, 2026
PubMed
Summary

Genetic testing and cardiac MRI aid sudden cardiac death risk stratification in hypertrophic cardiomyopathy (HCM) when standard markers are unclear. Family-based genetic evaluation is crucial for personalized risk assessment.